Dividends Calendar Earnings Calendar
ALNY

ALNY | Alnylam Pharmaceuticals Inc

Healthcare sector
Alnylam Pharmaceuticals Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Cambridge, Massachusetts, United States
  • Number of employees::   1,323 (2019)
Investor Relations : investors.alnylam.com

About the Company

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

  • Subsidiaries:   Sirna Therapeutics, Regulus Therapeutics Inc.

    Key Persons / Board of Directors

    • CEO :  John Maraganore (Dec 2002–)

    Videos about Alnylam Pharmaceuticals Inc



    Jump to (Finance sites)

    Google     
             

    Research 


    Investor page

    investors.alnylam.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 42
    HOLD 58
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInYoutube

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet